209 related articles for article (PubMed ID: 15349957)
1. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.
Ashok B; Arleth L; Hjelm RP; Rubinstein I; Onyüksel H
J Pharm Sci; 2004 Oct; 93(10):2476-87. PubMed ID: 15349957
[TBL] [Abstract][Full Text] [Related]
2. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs.
Krishnadas A; Rubinstein I; Onyüksel H
Pharm Res; 2003 Feb; 20(2):297-302. PubMed ID: 12636171
[TBL] [Abstract][Full Text] [Related]
3. Detailed structure of hairy mixed micelles formed by phosphatidylcholine and PEGylated phospholipids in aqueous media.
Arleth L; Ashok B; Onyuksel H; Thiyagarajan P; Jacob J; Hjelm RP
Langmuir; 2005 Apr; 21(8):3279-90. PubMed ID: 15807565
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs.
Sezgin Z; Yüksel N; Baykara T
Eur J Pharm Biopharm; 2006 Nov; 64(3):261-8. PubMed ID: 16884896
[TBL] [Abstract][Full Text] [Related]
5. Poly(ethylene glycol)-conjugated phospholipids in aqueous micellar solutions: hydration, static structure, and interparticle interactions.
Sato T; Sakai H; Sou K; Buchner R; Tsuchida E
J Phys Chem B; 2007 Feb; 111(6):1393-401. PubMed ID: 17286354
[TBL] [Abstract][Full Text] [Related]
6. Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP(1-38) in pegylated phospholipid micelles.
Ashok B; Rubinstein I; Tsueshita T; Onyüksel H
Peptides; 2004 Aug; 25(8):1253-8. PubMed ID: 15350692
[TBL] [Abstract][Full Text] [Related]
7. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles.
Sou K; Endo T; Takeoka S; Tsuchida E
Bioconjug Chem; 2000; 11(3):372-9. PubMed ID: 10821653
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
Chandran T; Katragadda U; Teng Q; Tan C
Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids.
Craparo EF; Teresi G; Bondi' ML; Licciardi M; Cavallaro G
Int J Pharm; 2011 Mar; 406(1-2):135-44. PubMed ID: 21185363
[TBL] [Abstract][Full Text] [Related]
11. Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles.
Lim SB; Rubinstein I; Onyüksel H
Int J Pharm; 2008 May; 356(1-2):345-50. PubMed ID: 18289811
[TBL] [Abstract][Full Text] [Related]
12. Effect of cholesterol on the release of amphotericin B from PEG-phospholipid micelles.
Vakil R; Kwon GS
Mol Pharm; 2008; 5(1):98-104. PubMed ID: 18159926
[TBL] [Abstract][Full Text] [Related]
13. Mixing behavior of a poly(ethylene glycol)-grafted phospholipid in monolayers at the air/water interface.
Tsoukanova V; Salesse C
Langmuir; 2008 Nov; 24(22):13019-29. PubMed ID: 18942801
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation.
Gill KK; Nazzal S; Kaddoumi A
Eur J Pharm Biopharm; 2011 Oct; 79(2):276-84. PubMed ID: 21575719
[TBL] [Abstract][Full Text] [Related]
15. Influence of preparation path on the formation of discs and threadlike micelles in DSPE-PEG(2000)/lipid systems.
Sandström MC; Johansson E; Edwards K
Biophys Chem; 2008 Feb; 132(2-3):97-103. PubMed ID: 18006210
[TBL] [Abstract][Full Text] [Related]
16. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer.
Garbuzenko O; Barenholz Y; Priev A
Chem Phys Lipids; 2005 Jun; 135(2):117-29. PubMed ID: 15921973
[TBL] [Abstract][Full Text] [Related]
17. Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine.
Rupp C; Steckel H; Müller BW
Int J Pharm; 2010 Aug; 395(1-2):272-80. PubMed ID: 20580793
[TBL] [Abstract][Full Text] [Related]
18. Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs.
Moribe K; Maruyama S; Inoue Y; Suzuki T; Fukami T; Tomono K; Higashi K; Tozuka Y; Yamamoto K
Int J Pharm; 2010 Mar; 387(1-2):236-43. PubMed ID: 20005934
[TBL] [Abstract][Full Text] [Related]
19. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
Alvarez C; Shin DH; Kwon GS
Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
[TBL] [Abstract][Full Text] [Related]
20. Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles.
Kastantin M; Ananthanarayanan B; Karmali P; Ruoslahti E; Tirrell M
Langmuir; 2009 Jul; 25(13):7279-86. PubMed ID: 19358585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
